agilon health (NYSE:AGL) Trading Up 5.6% After Analyst Upgrade

agilon health, inc. (NYSE:AGL)’s stock price traded up 5.6% during mid-day trading on Thursday after Royal Bank of Canada raised their price target on the stock from $3.00 to $3.50. Royal Bank of Canada currently has an outperform rating on the stock. agilon health traded as high as $3.58 and last traded at $3.55. 318,263 shares changed hands during mid-day trading, a decline of 94% from the average session volume of 5,431,873 shares. The stock had previously closed at $3.36.

AGL has been the topic of several other reports. TD Cowen reduced their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Macquarie initiated coverage on shares of agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price objective for the company. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and upped their price objective for the company from $1.75 to $2.25 in a research note on Friday, January 10th. Finally, Barclays decreased their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $3.95.

Insider Buying and Selling

In other agilon health news, Director Karen Mcloughlin purchased 25,000 shares of the company’s stock in a transaction that occurred on Friday, December 13th. The stock was bought at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the purchase, the director now directly owns 73,166 shares of the company’s stock, valued at $160,965.20. The trade was a 51.90 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director John William Wulf purchased 45,000 shares of the business’s stock in a transaction that occurred on Thursday, December 5th. The stock was bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 77,500 shares of company stock valued at $169,600 over the last ninety days. 3.20% of the stock is owned by insiders.

Hedge Funds Weigh In On agilon health

A number of institutional investors have recently bought and sold shares of AGL. Captrust Financial Advisors grew its holdings in shares of agilon health by 10.9% during the 4th quarter. Captrust Financial Advisors now owns 35,485 shares of the company’s stock worth $67,000 after acquiring an additional 3,494 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of agilon health by 2.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company’s stock valued at $393,000 after purchasing an additional 5,107 shares in the last quarter. MetLife Investment Management LLC boosted its position in shares of agilon health by 4.0% during the fourth quarter. MetLife Investment Management LLC now owns 174,551 shares of the company’s stock valued at $332,000 after purchasing an additional 6,762 shares in the last quarter. Symphony Financial Services Inc. grew its stake in agilon health by 44.3% in the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock worth $44,000 after purchasing an additional 7,058 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in agilon health in the third quarter worth $28,000.

agilon health Price Performance

The firm has a market cap of $1.38 billion, a PE ratio of -3.56 and a beta of 0.66. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a 50-day simple moving average of $2.94 and a 200 day simple moving average of $3.04.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.